Phase I Trial of Poly E in Barrett's Esophagus

In conclusion, Poly E was well-tolerated, and treatment with Poly E (400 and 600 mg) but not Poly E (200 mg) or placebo resulted in clinically relevant and detectable EGCG accumulation in the target organ, esophageal mucosa. Cancer Prev Res; 8(12); 1131–7. ©2015 AACR.

Source: Cancer Prevention Research - December 3, 2015 Category: Cancer & Oncology Authors: Joe, A. K., Schnoll-Sussman, F., Bresalier, R. S., Abrams, J. A., Hibshoosh, H., Cheung, K., Friedman, R. A., Yang, C. S., Milne, G. L., Liu, D. D., Lee, J. J., Abdul, K., Bigg, M., Foreman, J., Su, T., Wang, X., Ahmed, A., Neugut, A. I., Akpa, E., Lippma Tags: Research Articles Source Type: research